Gallstone pancreatitis caused by ceftriaxone

Pediatric Infectious Disease Journal

Volumn 17, Issue 7, 1998, Pages 662-663

  Maranan, Melinda C ^a   Gerber, Susan I ^b   Miller, Grant G ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Ceftriaxone; Cholelithiasis; Pancreatitis

Indexed keywords

AMPICILLIN; CEFTRIAXONE; GENTAMICIN; METRONIDAZOLE; NAFCILLIN; VANCOMYCIN;

ABSCESS DRAINAGE; ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CRANIOTOMY; FACE SURGERY; FRONTAL SINUSITIS; GALLSTONE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; PRIORITY JOURNAL; SUBDURAL EMPYEMA;

ADOLESCENT; CEFTRIAXONE; CEPHALOSPORINS; CHOLELITHIASIS; EMPYEMA, SUBDURAL; HUMANS; MALE; PANCREATITIS;

EID: 0031874256     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199807000-00022     Document Type: Article

References (10)

1. Schaad UB, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 1988;2:1411-3.
2. Schaad UB, Tschappeler H, Lentze MJ. Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis 1986;5:708-10.
3. Heim-Duthoy KL, Caperton EM, Pollock R, Matzke GR, Enthoven D, Peterson PK. Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother 1990;34:1146-9.
4. Robertson FM, Crombleholme TM, Barlow SE, Verhave M, Brown D. Ceftriaxone choledocholithiasis. Pediatrics 1996; 98:133-4.
5. Lopez AJ, O'Keefe P, Morrissey M, Pickleman J. Ceftriaxone-induced cholelithiasis. Ann Intern Med 1991;115:712-4.
6. Zinberg J, Chernaik R, Coman E, Rosenblatt R, Brandt LJ. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis. Am J Gastroenterol 1991;86:1251-4.
7. Jacobs RF. Ceftriaxone-associated cholecystitis. Pediatr Infect Dis J 1988;7:434-6.
8. Kim YS, Kestell MF, Lee SP. Gallbladder sludge: lessons from ceftriaxone. J Gastroenterol Hepatol 1992;7:618-21.
9. Xia Y, Lambert KJ, Schteingart CD, Gu J, Hofmann AF. Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile. Gastroenterology 1990;99:454-65.
10. Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge: in vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology 1990;99: 1772-8.